Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli

Future Microbiology

Volumn 6, Issue 3, 2011, Pages 317-333

  Zhao, Wei Hua ^a   Hu, Zhi Qing ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gram negative bacilli; integrons; metallo lactamases; VIM type lactamases

Indexed keywords

AMINO ACID; CARBAPENEM; METALLO BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; BACILLI; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; CITROBACTER FREUNDII; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; GENE CASSETTE; INTEGRON; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MICROBIAL DIVERSITY; MORGANELLA MORGANII; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PLASMID; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROVIDENCIA STUARTII; PSEUDOMONAS AERUGINOSA; REVIEW; TRANSPOSON;

BETA-LACTAMASES; DNA TRANSPOSABLE ELEMENTS; GENETIC VARIATION; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; INTEGRONS; PLASMIDS; SEQUENCE HOMOLOGY, AMINO ACID;

BACILLI (CLASS); NEGIBACTERIA;

EID: 79953298441     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.11.13     Document Type: Review

References (128)

1. Zhao W-H, Hu Z-Q: β-lactamases identified in clinical isolates of Pseudomonas aeruginosa. Crit. Rev. Microbiol. 36, 245-258 (2010). Recent review of β-lactamases derived from Gram-negative bacilli focused on Pseudomonas aeruginosa.
2. Ambler RP: The structure of β-lactamases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 289, 321-331 (1980).
3. Waley SG: β-lactamase: mechanism of action. In: The Chemistry of β-lactams. Page MI (Ed.). Chapman and Hall, London, UK, 198-228 (1992).
4. Walsh TR, Toleman MA, Poirel L, Nordmann P: Metallo-β-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18, 306-325 (2005). Expert overview of metallo-β-lactamases.
5. Poirel L, Pitout JD, Nordmann P: Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2, 501-512 (2007).
6. Nicolau DP: Carbapenems: a potent class of antibiotics. Expert Opin. Pharmacother. 9, 23-37 (2008).
7. Pérez-Llarena FJ, Bou G: β-lactamase inhibitors: the story so far. Curr. Med. Chem. 16, 3740-3765 (2009).
8. Zhao W-H, Hu Z-Q, Chen G, Matsushita K, Fukuchi K, Shimamura T: Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type β-lactamases encoded on a single plasmid. Microbiol. Res. 162, 46-52 (2007).
9. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 49, 4485-4491 (2005).
10. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53, 5046-5054 (2009).
11. Poirel L, Rodríguez-Martínez JM, Al Naiemi N, Debets-Ossenkopp YJ, Nordmann P: Characterization of DIM-1, an integron-encoded metallo-β-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands. Antimicrob. Agents Chemother. 54, 2420-2424 (2010).
12. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43, 1584-1590 (1999). First report of VIM-type metallo-β lactamases.
13. VIM-1-containing integron carrying a new aminoglycoside phosphotransferase gene cassette. Antimicrob. Agents Chemother. 45, 1249-1253 (2001).
14. Vatopoulos A: High rates of metallo-β-lactamase- producing Klebsiella pneumoniae in Greece-a review of the current evidence. Euro. Surveill. 13(4), pii: 8023 (2008).
15. Poirel L, Naas T, Nicolas D et al.: Characterization of VIM-2, a carbapenemhydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44, 891-897 (2000).
16. Giakkoupi P, Petrikkos G, Tzouvelekis LS et al.: Spread of integron-associated VIM-type metallo-β-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals. J. Clin. Microbiol. 41, 822-825 (2003).
17. Rossolini GM, Luzzaro F, Migliavacca R et al.: First countrywide survey of acquired metallo-β-lactamases in gram-negative pathogens in Italy. Antimicrob. Agents Chemother. 52, 4023-4029 (2008).
18. Nishio H, Komatsu M, Shibata N et al.: Metallo-β-lactamase-producing gramnegative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. J. Clin. Microbiol. 42, 5256-5263 (2004).
19. Stokes HW, Hall RM: A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol. Microbiol. 3, 1669-1683 (1989). First description of integrons as mobile DNA elements that can capture genes by site-specific recombination.
20. Hansson K, Sundström L, Pelletier A, Roy PH: IntI2 integron integrase in Tn7. J. Bacteriol. 184, 1712-1721 (2002).
21. IMP. Antimicrob. Agents Chemother. 39, 1612-1615 (1995).
22. Mazel D, Dychinco B, Webb VA, Davies J: A distinctive class of integron in the Vibrio cholerae genome. Science 280, 605-608 (1998).
23. Clark CA, Purins L, Kaewrakon P, Focareta T, Manning PA: The Vibrio cholerae O1 chromosomal integron. Microbiology 146, 2605-2612 (2000).
24. Nield BS, Holmes AJ, Gillings MR et al.: Recovery of new integron classes from environmental DNA. FEMS Microbiol. Lett. 195, 59-65 (2001).
25. Mazel D: Integrons: agents of bacterial evolution. Nat. Rev. Microbiol. 4, 608-620 (2006). Expert review of integrons with a particular focus on their structures and bacterial evolution.
26. Bennett PM: Integrons and gene cassettes: a genetic construction kit for bacteria. J. Antimicrob. Chemother. 43, 1-4 (1999).
27. VIM-2 in Pseudomonas putida. Antimicrob. Agents Chemother. 50, 2889-2891 (2006).
28. Ramirez MS, Tolmasky ME: Aminoglycoside modifying enzymes. Drug Resist. Updat. 13, 151-171 (2010).
29. Naas T, Nordmann P: OXA-type β-lactamases. Curr. Pharm. Des. 5, 865-879 (1999).
30. VIM-2 in clinical isolates of Pseudomonas aeruginosa. J. Med. Microbiol. 58, 1080-1085 (2009).
31. IMP-10 in clinical isolates of Serratia marcescens. J. Med. Microbiol. 58, 217-221 (2009).
32. Anderson KF, Lonsway DR, Rasheed JK et al.: Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45, 2723-2725 (2007).
33. Arakawa Y, Shibata N, Shibayama K et al.: Convenient test for screening metallo-β-lactamase- producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 38, 40-43 (2000).
34. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y: Imipenem-EDTA disk method for differentiation of metallo-β-lactamase- producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40, 3798-3801 (2002).
35. Picão RC, Andrade SS, Nicoletti AG et al.: Metallo-β-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J. Clin. Microbiol. 46, 2028-2037 (2008).
36. Walsh TR, Bolmström A, Qwärnström A, Gales A: Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing. J. Clin. Microbiol. 40, 2755-2759 (2002).
37. Tsakris A, Pournaras S, Woodford N et al.: Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38, 1290-1292 (2000).
38. Corvec S, Poirel L, Decousser JW, Allouch PY, Drugeon H, Nordmann P: Emergence of carbapenem-hydrolysing metallo-β-lactamase VIM-1 in Pseudomonas aeruginosa isolates in France. Clin. Microbiol. Infect. 12, 941-942 (2006).
39. VIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 54, 320-327 (2010).
40. Lombardi G, Luzzaro F, Docquier JD et al.: Nosocomial infections caused by multidrug-resistant isolates of Pseudomonas putida producing VIM-1 metallo-β-lactamase. J. Clin. Microbiol. 40, 4051-4055 (2002).
41. Miriagou V, Tzelepi E, Gianneli D, Tzouvelekis LS: Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-β-lactamase VIM-1. Antimicrob. Agents Chemother. 47, 395-397 (2003).
42. Tórtola MT, Lavilla S, Miró E et al.: First detection of a carbapenem-hydrolyzing metalloenzyme in two Enterobacteriaceae isolates in Spain. Antimicrob. Agents Chemother. 49, 3492-3494 (2005).
43. Giakkoupi P, Xanthaki A, Kanelopoulou M et al.: VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J. Clin. Microbiol. 41, 3893-3896 (2003).
44. Lartigue MF, Poirel L, Nordmann P: First detection of a carbapenem-hydrolyzing metalloenzyme in an Enterobacteriaceae isolate in France. Antimicrob. Agents Chemother. 48, 4929-4930 (2004).
45. VIM-1 and aac(6′)-IIc in an Enterobacter cloacae clinical isolate from Greece. J. Antimicrob. Chemother. 55, 634-638 (2005).
46. Tsakris A, Ikonomidis A, Pournaras S et al.: VIM-1 metallo-β- lactamase in Acinetobacter baumannii. Emerg. Infect. Dis. 12, 981-983 (2006).
47. VIM-1 metallo-β-lactamase gene. Clin. Microbiol. Infect. 12, 691-694 (2006).
48. Galani I, Souli M, Koratzanis E, Koratzanis G, Chryssouli Z, Giamarellou H: Emerging bacterial pathogens: Escherichia coli, Enterobacter aerogenes and Proteus mirabilis clinical isolates harbouring the same transferable plasmid coding for metallo-β-lactamase VIM-1 in Greece. J. Antimicrob. Chemother. 59, 578-579 (2007).
49. Tsakris A, Ikonomidis A, Spanakis N, Poulou A, Pournaras S: Characterization of In3Mor, a new integron carrying VIM-1 metallo-β- lactamase and sat1 gene, from Morganella morganii. J. Antimicrob. Chemother. 59, 739-741 (2007).
50. Weile J, Rahmig H, Gfröer S, Schroeppel K, Knabbe C, Susa M: First detection of a VIM-1 metallo-β-lactamase in a carbapenem-resistant Citrobacter freundii clinical isolate in an acute hospital in Germany. Scand. J. Infect. Dis. 39, 264-266 (2007).
51. Miriagou V, Tzouvelekis LS, Flevari K, Tsakiri M, Douzinas EE: Providencia stuartii with VIM-1 metallo-β-lactamase. J. Antimicrob. Chemother. 60, 183-184 (2007).
52. Duljasz W, Gniadkowski M, Sitter S, Wojna A, Jebelean C: First organisms with acquired metallo-β-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria. Antimicrob. Agents Chemother. 53, 2221-2222 (2009).
53. Deplano A, Rodriguez-Villalobos H, Glupczynski Y et al.: Emergence and dissemination of multidrug resistant clones of Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in Belgium. Euro Surveill. 12, E070118.2 (2007).
54. Pitout JD, Chow BL, Gregson DB, Laupland KB, Elsayed S, Church DL: Molecular epidemiology of metallo-β-lactamase- producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates. J. Clin. Microbiol. 45, 294-298 (2007).
55. Wang C, Wang J, Mi Z: Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamases and carrying two aminoglycosidemodifying enzymes in China. J. Hosp. Infect. 62, 522-524 (2006).
56. Villegas MV, Lolans K, del Rosario Olivera M et al.: First detection of metallo-β-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia. Antimicrob. Agents Chemother. 50, 226-229 (2006).
57. Sardelic S, Pallecchi L, Punda-Polic V, Rossolini GM: Carbapenem-resistant Pseudomonas aeruginosa-carrying VIM-2 metallo-β- lactamase determinants, Croatia. Emerg. Infect. Dis. 9, 1022-1023 (2003).
58. Henrichfreise B, Wiegand I, Sherwood KJ, Wiedemann B: Detection of VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Germany. Antimicrob. Agents Chemother. 49, 1668-1669 (2005).
59. Mavroidi A, Tsakris A, Tzelepi E, Pournaras S, Loukova V, Tzouvelekis LS: Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece. J. Antimicrob. Chemother. 46, 1041-1042 (2000).
60. Libisch B, Watine J, Balogh B et al.: Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary. Res. Microbiol. 159, 162-168 (2008).
61. VIM-2- harboring integrons isolated in India, Russia, and the United States arise from an ancestral class 1 integron predating the formation of the 3′ conserved sequence. Antimicrob. Agents Chemother. 51, 2636-2638 (2007).
62. VIM-2-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-β-lactamase. FEMS Microbiol. Lett. 195, 145-150 (2001).
63. Pitout JD, Revathi G, Chow BL et al.: Metallo-β-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya. Clin. Microbiol. Infect. 14, 755-759 (2008).
64. Lee K, Lim JB, Yum JH et al.: blaVIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob. Agents Chemother. 46, 1053-1058 (2002).
65. Khosravi Y, Tee Tay S, Vadivelu J: Metallo-β-lactamase-producing imipenem-resistant Pseudomonas aeruginosa clinical isolates in a university teaching hospital in Malaysia: detection of IMP-7 and first identification of IMP-4, VIM-2, and VIM-11. Diagn. Microbiol. Infect. Dis. 67, 294-296 (2010).
66. Cardoso O, Leitão R, Figueiredo A, Sousa JC, Duarte A, Peixe LV: Metallo-β-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal. Microb. Drug Resist. 8, 93-97 (2002).
67. VIM-2 in Eastern Europe: report from the SENTRY Antimicrobial Surveillance Program. J. Antimicrob. Chemother. 52, 116-119 (2003).
68. Guerin F, Henegar C, Spiridon G, Launay O, Salmon-Ceron D, Poyart C: Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-β-lactamase gene from Saudi Arabia. J. Antimicrob. Chemother. 56, 601-602 (2005).
69. Lepsanovic Z, Libisch B, Tomanovic B, Nonkovici Z, Balogh B, Füzi M: Characterisation of the first VIM metallo-β-lactamase- producing Pseudomonas aeruginosa clinical isolate in Serbia. Acta Microbiol. Immunol. Hung. 55, 447-454 (2008).
70. IMP-26 gene. J. Clin. Microbiol. 48, 2563-2564 (2010).
71. Peña C, Suarez C, Tubau F et al.: Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications. Clin. Microbiol. Infect. 13, 1026-1029 (2007).
72. Yan JJ, Hsueh PR, Lu JJ, Chang FY, Ko WC, Wu JJ: Characterization of acquired β-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons. J. Antimicrob. Chemother. 58, 530-536 (2006).
73. Mansour W, Poirel L, Bettaieb D, Bouallegue O, Boujaafar N, Nordmann P: Metallo-β-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia. Diagn. Microbiol. Infect. Dis. 64, 458-461 (2009).
74. Yakupogullari Y, Poirel L, Bernabeu S, Kizirgil A, Nordmann P: Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum β-lactamase PER-1 and metallo-β-lactamase VIM-2 from Turkey. J. Antimicrob. Chemother. 61, 221-222 (2008).
75. Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP: First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States. Antimicrob. Agents Chemother. 49, 3538-3540 (2005).
76. VIM-2 in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 48, 1433-1434 (2004).
77. Yan JJ, Hsueh PR, Ko WC et al.: Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 45, 2224-2228 (2001).
78. Shibata N, Doi Y, Yamane K et al.: PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J. Clin. Microbiol. 41, 5407-5413 (2003).
79. Almuzara M, Radice M, de Gárate N et al.: VIM-2-producing Pseudomonas putida, Buenos Aires. Emerg. Infect. Dis. 13, 668-669 (2007).
80. Bogaerts P, Huang TD, Rodriguez-Villalobos H et al.: Nosocomial infections caused by multidrug-resistant Pseudomonas putida isolates producing VIM-2 and VIM-4 metallo-β-lactamases. J. Antimicrob. Chemother. 61, 749-751 (2008).
81. Treviño M, Moldes L, Hernández M, Martínez-Lamas L, García-Riestra C, Regueiro BJ: Nosocomial infection by VIM-2 metallo-β-lactamase-producing Pseudomonas putida. J. Med. Microbiol. 59, 853-855 (2010).
82. VIM-2 in an environmental isolate of Pseudomonas pseudoalcaligenes. Antimicrob. Agents Chemother. 49, 2140-2141 (2005).
83. Yum JH, Yong D, Lee K, Kim HS, Chong Y: A new integron carrying VIM-2 metallo-β-lactamase gene cassette in a Serratia marcescens isolate. Diagn. Microbiol. Infect. Dis. 42, 217-219 (2002).
84. Yum JH, Yi K, Lee H et al.: Molecular characterization of metallo-β-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the blaVIM-2 gene cassettes. J. Antimicrob. Chemother. 49, 837-840 (2002).
85. Canduela MJ, Gallego L, Sevillano E, Valderrey C, Calvo F, Pérez J: Evolution of multidrug-resistant Acinetobacter baumannii isolates obtained from elderly patients with respiratory tract infections. J. Antimicrob. Chemother. 57, 1220-1222 (2006).
86. Lee MF, Peng CF, Hsu HJ, Chen YH: Molecular characterisation of the metallo-β-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan. Int. J. Antimicrob. Agents 32, 475-480 (2008).
87. Lee K, Kim CK, Hong SG et al.: Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-β-lactamases. Int. J. Antimicrob. Agents 36, 259-263 (2010).
88. Lim YM, Shin KS, Kim J: Distinct antimicrobial resistance patterns and antimicrobial resistance-harboring genes according to genomic species of Acinetobacter isolates. J. Clin. Microbiol. 45, 902-905 (2007).
89. Yan JJ, Ko WC, Chuang CL, Wu JJ: Metallo-β-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J. Antimicrob. Chemother. 50, 503-511 (2002).
90. Lee HK, Park YJ, Kim JY et al.: Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases. Diagn. Microbiol. Infect. Dis. 52, 331-336 (2005).
91. Jeong SH, Lee K, Chong Y et al.: Characterization of a new integron containing VIM-2, a metallo-β-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. J. Antimicrob. Chemother. 51, 397-400 (2003).
92. VIM-2-carrying integron among Enterobacteriaceae species in Mexico: report from the SENTRY Antimicrobial Surveillance Program. Microb. Drug Resist. 15, 33-35 (2009).
93. Galani I, Souli M, Chryssouli Z, Katsala D, Giamarellou H: First identification of an Escherichia coli clinical isolate producing both metallo-β-lactamase VIM-2 and extended-spectrum β-lactamase IBC-1. Clin. Microbiol. Infect. 10, 757-760 (2004).
94. Yong D, Choi YS, Roh KH et al.: Increasing prevalence and diversity of metallo-β-lactamases in Pseudomonas spp., Acinetobacter spp., and Enterobacteriaceae from Korea. Antimicrob. Agents Chemother. 50, 1884-1886 (2006).
95. VIM-2 in Klebsiella oxytoca clinical isolates from Portugal. Antimicrob. Agents Chemother. 49, 476 (2005).
96. VIM-2-containing class 1 integron. Diagn. Microbiol. Infect. Dis. 53, 215-220 (2005).
97. Sofianou D, Markogiannakis A, Metzidie E, Pournaras S, Tsakris A: VIM-2 metallo-β-lactamase in Achromobacter xylosoxidans in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 24, 854-855 (2005).
98. VIM-2, and armA. J. Microbiol. 45, 272-274 (2007).
99. VIM-1 in a clinical strain of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46, 4026-4028 (2002).
100. Giske CG, Rylander M, Kronvall G: VIM-4 in a carbapenem-resistant strain of Pseudomonas aeruginosa isolated in Sweden. Antimicrob. Agents Chemother. 47, 3034-3035 (2003).
101. VIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001). J. Antimicrob. Chemother. 53, 451-456 (2004).
102. VIM-4 type metallo-β-lactamase gene from a carbapenem-resistant Pseudomonas aeruginosa clinical isolate in Hungary. Antimicrob. Agents Chemother. 48, 3576-3578 (2004).
103. Peleg AY, Bell JM, Hofmeyr A, Wiese P: Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymes. J. Antimicrob. Chemother. 57, 794-795 (2006).
104. Luzzaro F, Docquier JD, Colinon C et al.: Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-β-lactamase encoded by a conjugative plasmid. Antimicrob. Agents Chemother. 48, 648-650 (2004).
105. Ktari S, Arlet G, Mnif B et al.: Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-β-lactamase, CTX-M-15 extended-spectrum β-lactamase, and CMY-4 AmpC β-lactamase in a Tunisian university hospital. Antimicrob. Agents Chemother. 50, 4198-4201 (2006).
106. VIM-4 gene in the internationally successful Klebsiella pneumoniae ST11 clone and in a Klebsiella oxytoca strain in Hungary. J. Antimicrob. Chemother. 65, 1303-1305 (2010).
107. Ikonomidis A, Spanakis N, Poulou A, Pournaras S, Markou F, Tsakris A: Emergence of carbapenem-resistant Enterobacter cloacae carrying VIM-4 metallo-β-lactamase and SHV-2a extended-spectrum β-lactamase in a conjugative plasmid. Microb. Drug Resist. 13, 221-226 (2007).
108. Figueiredo S, Poirel L, Papa A, Koulourida V, Nordmann P: First identification of VIM-4 metallo-β-lactamase in Acinetobacter spp. Clin. Microbiol. Infect. 14, 289-290 (2008).
109. Libisch B, Giske CG, Kovács B, Tóth TG, Füzi M: Identification of the first VIM metallo-β-lactamase-producing multiresistant Aeromonas hydrophila strain. J. Clin. Microbiol. 46, 1878-1880 (2008).
110. Bahar G, Mazzariol A, Koncan R et al.: Detection of VIM-5 metallo-β-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey. J. Antimicrob. Chemother. 54, 282-283 (2004).
111. Castanheira M, Bell JM, Turnidge JD, Mathai D, Jones RN: Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-β-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18). Antimicrob. Agents Chemother. 53, 1225-1227 (2009).
112. Gacar GG, Midilli K, Kolayli F et al.: Genetic and enzymatic properties of metallo-β-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae. Antimicrob. Agents Chemother. 49, 4400-4403 (2005).
113. Poirel L, Yakupoǧullari Y, Kizirgil A, Dogukan M, Nordmann P: VIM-5 metallo-β-lactamase- producing Pseudomonas putida from Turkey. Int. J. Antimicrob. Agents 33, 287 (2009).
114. Koh TH, Wang GC, Sng LH: IMP-1 and a novel metallo-β-lactamase, VIM-6, in fluorescent pseudomonads isolated in Singapore. Antimicrob. Agents Chemother. 48, 2334-2336 (2004).
115. VIM-6 among Pseudomonas aeruginosa isolates in Asian-Pacific Nations. Clin. Microbiol. Infect. 16, 186-189 (2010).
116. VIM-7, an evolutionarily distinct metallo-β-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob. Agents Chemother. 48, 329-332 (2004).
117. Crespo MP, Woodford N, Sinclair A et al.: Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-β-lactamase, in a tertiary care center in Cali, Colombia. J. Clin. Microbiol. 42, 5094-5101 (2004).
118. VIM family in a GES-1 extended-spectrum-β- lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Antimicrob. Agents Chemother. 49, 474-475 (2005).
119. Pournaras S, Ikonomidis A, Tzouvelekis LS et al.: VIM-12, a novel plasmid-mediated metallo-β-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid. Antimicrob. Agents Chemother. 49, 5153-5156 (2005).
120. Ikonomidis A, Labrou M, Afkou Z et al.: First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-β-lactamase VIM-12. Antimicrob. Agents Chemother. 51, 3038-3039 (2007).
121. Kontou M, Pournaras S, Kristo I, Ikonomidis A, Maniatis AN, Stathopoulos C: Molecular cloning and biochemical characterization of VIM-12, a novel hybrid VIM-1/VIM-2 metallo-β-lactamase from a Klebsiella pneumoniae clinical isolate, reveal atypical substrate specificity. Biochemistry 46, 13170-13178 (2007).
122. Panopoulou M, Alepopoulou E, Ikonomidis A, Grapsa A, Paspalidou E, Kartali-Ktenidou S: Emergence of VIM-12 in Enterobacter cloacae. J. Clin. Microbiol. 48, 3414-3415 (2010).
123. Juan C, Beceiro A, Gutiérrez O et al.: Characterization of the new metallo-β-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain. Antimicrob. Agents Chemother. 52, 3589-3596 (2008).
124. Schneider I, Keuleyan E, Rasshofer R, Markovska R, Queenan AM, Bauernfeind A: VIM-15 and VIM-16, two new VIM-2-like metallo-β-lactamases in Pseudomonas aeruginosa isolates from Bulgaria and Germany. Antimicrob. Agents Chemother. 52, 2977-2979 (2008).
125. VIM-17 metallo-β-lactamase gene. Antimicrob. Agents Chemother. 53, 1325-1330 (2009).
126. Robin F, Aggoune-Khinache N, Delmas J, Naim M, Bonnet R: Novel VIM metallo-β-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria. Antimicrob. Agents Chemother. 54, 466-470 (2010).
127. Pournaras S, Poulou A, Voulgari E, Vrioni G, Kristo I, Tsakris A: Detection of the new metallo-β-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae. J. Antimicrob. Chemother. 65, 1604-1607 (2010).
128. Jacoby GA, Bush K: β-lactamase classification and amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes. www.lahey.org/Studies A database of β-lactamases.